|
Ajooni Biotech Ltd.
|
Notes to Accounts
|
|
|
|
|
|
|
You can view the entire text of Notes to accounts of the company for the latest year
|
|
Market Cap. (Rs.)
|
134.18 Cr.
|
P/BV
|
1.62
|
Book Value (Rs.)
|
4.82
|
|
52 Week High/Low (Rs.)
|
10/5
|
FV/ML
|
2/1
|
P/E(X)
|
62.12
|
|
Bookclosure
|
07/05/2024
|
EPS (Rs.)
|
0.13
|
Div Yield (%)
|
0.00
|
|
|
|
|
| Year End :2024-03 | 2. With reference to Employee Benefits, provision has been made regarding Gratuity, on basis of actuarial valuation and their impact on financial statements is ascertained in FY 2023-24, However impact in previous year remains unascertained.
6) The Balance in the parties account whether debit or credit are subject to confirmation, reconciliation and adjustment.
7) Estimated amount of contracts remaining to be executed on capital account and not provided for (Net of Advances).
|
8) Contingent Liabilities not provided for :
|
31st March, 2024
|
31st March, 2023
|
|
a. Bank Guarantees
|
Nil
|
Nil
|
|
b. Contingent Liabilities in respect of Unascertained Unassessed cases of Income Tax and Sales Tax.
|
Unascertained
|
|
c. Uncalled Liabilities as Shares partly paid
|
Nil
|
Nil
|
|
d. Claims not acknowledged as debts
|
Nil
|
Nil
|
|
e. Letter of Credit(s)
|
Nil
|
Nil
|
|
9) CIF value of imports
|
Nil
|
Nil
|
|
10) Remittance in foreign Currency
|
Nil
|
Nil
|
|
11) Expenditure in Foreign Currency
|
Nil
|
Nil
|
|
12) Earning in Foreign Currency
* Received on account of export sales
|
Rs. 14,69,325.00
|
Rs. 11,61,400.00
|
years, until such date when the interest dues as above are actually paid to the small enterprise, for the purpose of dis allowance as a deductible expenditure under section 23.
|
|
|
|
|
| |